Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Pfizer VP Has "No Qualifications" To Speak On Importation, Company Says

This article was originally published in The Pink Sheet Daily

Executive Summary

Pfizer is challenging the qualifications of one of its marketing executives to discuss reimportation

You may also be interested in...



Reimportation Advocates Have Support Of "Rogue" Pfizer Exec

Parallel trade of pharmaceuticals in Europe demonstrates that U.S. could safely implement an importation program, Pfizer VP-Marketing Peter Rost says at Capitol Hill press conference. Rost is a former Pharmacia exec who describes his advocacy as a "private citizen" sharing "personal experience."

Reimportation Advocates Have Support Of "Rogue" Pfizer Exec

Parallel trade of pharmaceuticals in Europe demonstrates that U.S. could safely implement an importation program, Pfizer VP-Marketing Peter Rost says at Capitol Hill press conference. Rost is a former Pharmacia exec who describes his advocacy as a "private citizen" sharing "personal experience."

"Canadian Generics" Website Products Differ In Potency From U.S. Versions, FDA Finds

FDA tests show a "generic" version of Ambien purchased through a website advertising "Canadian Generics" was more potent than the U.S. version. The "generic" Lipitor and Viagra were both subpotent.

Topics

UsernamePublicRestriction

Register

ID1128360

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel